TGFB1 and neoplasm: TGF-β1 activates the SMAD3 and ERK1/2 signaling pathways, inducing neutrophils in the tumor microenvironment to express tumor-promoting factors, such as OSM and VEGFA mRNA, thereby converting neutrophils into a pro-tumor phenotype [193].